109 related articles for article (PubMed ID: 2165403)
1. Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity.
Rowlands MG; Parr IB; McCague R; Jarman M; Goddard PM
Biochem Pharmacol; 1990 Jul; 40(2):283-9. PubMed ID: 2165403
[TBL] [Abstract][Full Text] [Related]
2. Rationally designed analogues of tamoxifen with improved calmodulin antagonism.
Hardcastle IR; Rowlands MG; Houghton J; Parr IB; Potter GA; Jarman M; Edwards KJ; Laughton CA; Trent JO; Neidle S
J Med Chem; 1995 Jan; 38(2):241-8. PubMed ID: 7830266
[TBL] [Abstract][Full Text] [Related]
3. Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues.
McCague R; Rowlands MG; Grimshaw R; Jarman M
Biochem Pharmacol; 1994 Oct; 48(7):1355-61. PubMed ID: 7945433
[TBL] [Abstract][Full Text] [Related]
4. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
[TBL] [Abstract][Full Text] [Related]
5. Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues.
Rowlands MG; Budworth J; Jarman M; Hardcastle IR; McCague R; Gescher A
Biochem Pharmacol; 1995 Aug; 50(5):723-6. PubMed ID: 7669076
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifen.
O'Brian CA; Ioannides CG; Ward NE; Liskamp RM
Biopolymers; 1990 Jan; 29(1):97-104. PubMed ID: 2158363
[TBL] [Abstract][Full Text] [Related]
7. 2-Aza-anthraquinones as inhibitors of the Ca(2+)- and calmodulin-dependent cyclic adenosine 3',5'-monophosphate phosphodiesterase.
Gräfe U; Römer W
Pharmazie; 1991 Apr; 46(4):297-8. PubMed ID: 1653425
[No Abstract] [Full Text] [Related]
8. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
Walsh MP; Sutherland C; Scott-Woo GC
Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.
Rowlands MG; Grimshaw R; Jarman M; Bouhoute A; Leclercq G
Biochem Pharmacol; 1997 Jan; 53(2):241-4. PubMed ID: 9037257
[TBL] [Abstract][Full Text] [Related]
10. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
Gulino A; Barrera G; Vacca A; Farina A; Ferretti C; Screpanti I; Dianzani MU; Frati L
Cancer Res; 1986 Dec; 46(12 Pt 1):6274-8. PubMed ID: 3022916
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and properties of some novel anti-calmodulin drugs.
Sakai TT; Krishna NR
Bioorg Med Chem; 1999 Aug; 7(8):1559-65. PubMed ID: 10482448
[TBL] [Abstract][Full Text] [Related]
12. Effects of KS-501, KS-502 and their enantiomers on calmodulin-sensitive enzyme activity and cellular proliferation.
Hait WN; Gesmonde J; Cheng E
Biochem Pharmacol; 1995 Jun; 50(1):69-74. PubMed ID: 7605347
[TBL] [Abstract][Full Text] [Related]
13. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibitors of calmodulin-dependent phosphodiesterase and other enzymes.
Hidaka H; Inagaki M; Nishikawa M; Tanaka T
Methods Enzymol; 1988; 159():652-60. PubMed ID: 2842626
[No Abstract] [Full Text] [Related]
15. Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens.
Barrera G; Screpanti I; Paradisi L; Parola M; Ferretti C; Vacca A; Farina A; Dianzani MU; Frati L; Gulino A
Biochem Pharmacol; 1986 Sep; 35(17):2984-6. PubMed ID: 3017367
[No Abstract] [Full Text] [Related]
16. Inhibition of calmodulin-dependent calcium-ATPase and phosphodiesterase by various cyclopeptides and peptide alkaloids from the Zizyphus species.
Hwang KH; Han YN; Han BH
Arch Pharm Res; 2001 Jun; 24(3):202-6. PubMed ID: 11440077
[TBL] [Abstract][Full Text] [Related]
17. Pyrrolo[2,3-d]pyrimidines as inhibitors of cAMP-phosphodiesterase. Structure-activity relationship.
Klumpp S; Frey M; Kleefeld G; Sauer A; Eger K
Biochem Pharmacol; 1989 Mar; 38(6):949-53. PubMed ID: 2539163
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of calmodulin dependent c-AMP-phosphodiesterase by moxaverine and papaverine.
Mannhold R
Arzneimittelforschung; 1988 Dec; 38(12):1806-8. PubMed ID: 2854468
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin B is a selective and potent antagonist of calmodulin.
Hegemann L; van Rooijen LA; Traber J; Schmidt BH
Eur J Pharmacol; 1991 May; 207(1):17-22. PubMed ID: 1915592
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds.
Picq M; Dubois M; Prigent AF; Némoz G; Pacheco H
Biochem Int; 1989 Jan; 18(1):47-57. PubMed ID: 2541724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
